CAMK2G and cardiomyopathy: In contrast, genetic and pharmacologic inhibition of CaMKII provides protection from chronic stress, limiting the development of cardiomyopathy and maintaining cardiac output in both ischemic and nonischemic disease models (30, 31, 32, 33).